Maste 150 150mg/ml 10ml Vial by Military Pharma

Usage

1. Confirm your competition date and count back 8 weeks to establish the start of your Maste 150 contest-prep block — this defines your total vial requirement and phase boundaries.
2. Draw your prescribed dose using a sterile needle; at 150mg/ml, a 100mg dose occupies 0.67ml and a 150mg dose occupies 1.0ml — confirm the volume against your syringe graduation before injecting.
3. Rotate injection sites on an every-other-day schedule (glutes, quads, delts in rotation) to prevent site overuse across the multi-week prep period.
4. After each draw, wipe the stopper with an alcohol swab and store the vial at 2–8°C to maintain oil-vehicle clarity and microbial integrity across the full 10ml volume.
5. At each weekly check-in (typically days 7, 14, 21 etc. from cycle start), assess physique response — subcutaneous water retention, vascularity, and muscle density — before deciding whether to maintain or escalate your weekly dose for the following phase.
6. Schedule your final injection at least 3 days before stage day to allow circulating Drostanolone Propionate levels to decline through the propionate half-life window, preserving muscle fullness while reducing peak-androgen water load ahead of prejudging.

Warnings

Frequently asked questions

How do competitive bodybuilders structure their Drostanolone Propionate dosing in the final weeks before a contest?

Most contest-prep athletes divide the pre-competition period into two or three phases, starting at 300–400mg per week roughly 8 weeks out and increasing to 400–600mg per week during the final 4 weeks as body-fat levels allow androgen response to be fully expressed. Every-other-day injection frequency is standard to maintain serum stability across the 2–3 day half-life. Maste 150's 150mg/ml concentration makes these weekly totals achievable with sub-1ml injection volumes.

When should a competitor make their final Drostanolone Propionate injection before stepping on stage?

Most experienced competitors schedule their last injection 3–5 days prior to the event. With a pharmacokinetic half-life of approximately 2–3 days, circulating Drostanolone Propionate levels decline predictably after the final dose, allowing athletes to manage the transition from peak-cycle androgen exposure to stage-day muscle fullness without abrupt hormonal withdrawal. Maste 150's propionate ester supports this timing with confidence.

What weekly dose of Drostanolone Propionate is considered standard for competitive athletes in peak conditioning?

Community-reported and practitioner-guided contest prep protocols place the standard peak-phase weekly dose between 400mg and 600mg for experienced competitors with confirmed body-fat levels below approximately 8–10%. This range is generally introduced during the final 4 weeks pre-contest. Beginner competitors or first-time prep athletes typically remain at 300–400mg per week throughout to assess individual response before escalating in subsequent contest cycles.

How does Maste 150's 150mg/ml concentration affect practical injection volumes during contest prep?

At 150mg/ml — the highest concentration in this Drostanolone Propionate product group — a 100mg dose requires only 0.67ml and a 150mg dose requires exactly 1.0ml. This keeps injection volumes below 1ml for the most common per-injection doses, reducing site discomfort during the high-frequency every-other-day schedule typical of contest prep. Compared to 100mg/ml formulations, the same weekly total is delivered in one-third less volume per injection.

Can Maste 150 be drawn with an insulin syringe, and how should the 10ml vial be stored after first use?

Yes — at sub-1ml volumes per injection, insulin syringes (typically 0.5ml or 1.0ml capacity) are compatible with Maste 150 for athletes preferring finer-gauge administration. After the rubber stopper is first punctured, the vial should be stored in a cool, dark environment (ideally 2–8°C refrigeration) away from direct light; the oil-based vehicle remains stable for the full multi-dose protocol duration when stored correctly and handled with sterile technique on each draw. (2) angle_used

Manufacturer

Military Pharma's injectable product portfolio is built around a deliberately narrow compound selection — single-ester oil-based androgens and anabolic steroids formulated to specific concentration specifications that reflect actual clinical and performance use patterns rather than industry convention. Within this portfolio, Maste 150 sits alongside other 150mg/ml injectable lines including Primo 150, Propionate 150, and Tren Ace 150, forming a coherent high-concentration tier designed for athletes operating at advanced dosing precision requirements. The portfolio architecture reflects a conscious product-line philosophy: each compound in the 150mg/ml tier addresses a distinct pharmacological role, yet shares a unified manufacturing standard — common GMP facility, batch release criteria including HPLC potency verification and LAL endotoxin control, and the 10ml multi-dose vial format — so athletes running multi-compound protocols source analytically comparable products from a single, audited production environment. This cross-compound consistency is a deliberate commercial and technical decision that differentiates Military Pharma's range from manufacturers whose compound-specific quality standards vary across product lines.